Crying wolf on drug safety.
出版信息
Br Med J (Clin Res Ed). 1982 Jan 23;284(6311):219-20.
Abstract
摘要
相似文献
1
Crying wolf on drug safety.
Br Med J (Clin Res Ed). 1982 Jan 23;284(6311):219-20.
2
Post-marketing surveillance of licensed medicinal and other products.
Health Bull (Edinb). 1981 Nov;39(6):356-66.
3
Symposium on drug safety. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. The situation in the United Kingdom.
Can Med Assoc J. 1968 Feb 10;98(6):271-5.
4
[Pharmacovigilance in the framework of recording and control of drugs in the United Kingdom].
Therapie. 1974 Nov-Dec;29(6):799-804.
5
[Intensified drug control--with drawbacks?].
Lakartidningen. 1983 Feb 16;80(7):575-81.
6
The Committee on Safety of Medicines.
Health Bull (Edinb). 1981 Nov;39(6):393-7.
7
Present attitudes of governmental drug regulatory agencies.
Int J Clin Pharmacol. 1973 Apr;7(2):168-77.
8
Compensating the drug victim.
Lancet. 1978 Jul 1;2(8079):26.
9
Editorial: The drug makers.
Med J Aust. 1974 Oct 19;2(16):583-4.
10
IV. Recent medicine legislation in the United Kingdom and its effect on manufacturing practice.
Bull Parenter Drug Assoc. 1974 Jul-Aug;28(4):174-80.
本文引用的文献
1
Debendox and congenital malformations in Northern Ireland.
Br Med J. 1980 Nov 22;281(6252):1379-81. doi: 10.1136/bmj.281.6252.1379.
2
A survey of products licensed in the United Kingdom from 1971-1981.
Br J Clin Pharmacol. 1981 Oct;12(4):453-63. doi: 10.1111/j.1365-2125.1981.tb01251.x.
3
Untoward effects associated with practolol administration: oculomucocutaneous syndrome.
Br Med J. 1975 Mar 15;1(5958):595-8. doi: 10.1136/bmj.1.5958.595.
4
Unusual fetal malformations after antiemetics in early pregnancy.
Br Med J. 1978 Mar 18;1(6114):691-2. doi: 10.1136/bmj.1.6114.691.
Zotero 插件